Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sigyn Therapeutics (SIGYD)
OTHER OTC:SIGYD
Sigyn Therapeutics (SIGYD) Stock Price & Analysis
11 Followers
SIGYD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.08 - $19.16
Previous Close$4.75
VolumeN/A
Average Volume (3M)279.00
Market Cap
N/A
Enterprise Value$8.88M
Total Cash (Recent Filing)$64.58K
Total Debt (Recent Filing)$3.15M
Price to Earnings (P/E)-1.2
Beta-0.11
Next Earnings
Nov 14, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.82
Shares Outstanding1,224,315
10 Day Avg. Volume171
30 Day Avg. Volume279
Standard Deviation0.38
R-Squared0.05
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)-2.16
Price to Sales (P/S)-42.82
Price to Cash Flow (P/CF)-5.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.23K
Enterprise Value/Gross Profit-65.42
Enterprise Value/Ebitda-3.30
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sigyn Therapeutics News
SIGYD FAQ
What was Sigyn Therapeutics’s price range in the past 12 months?
Sigyn Therapeutics lowest stock price was $2.08 and its highest was $19.16 in the past 12 months.
What is Sigyn Therapeutics’s market cap?
Currently, no data Available
When is Sigyn Therapeutics’s upcoming earnings report date?
Sigyn Therapeutics’s upcoming earnings report date is Nov 14, 2023 which is 169 days ago.
How were Sigyn Therapeutics’s earnings last quarter?
Sigyn Therapeutics released its earnings results on Aug 14, 2023. The company reported -$0.668 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.668.
Is Sigyn Therapeutics overvalued?
According to Wall Street analysts Sigyn Therapeutics’s price is currently same.
Does Sigyn Therapeutics pay dividends?
Sigyn Therapeutics does not currently pay dividends.
What is Sigyn Therapeutics’s EPS estimate?
Sigyn Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sigyn Therapeutics have?
Sigyn Therapeutics has 1,221,043 shares outstanding.
What happened to Sigyn Therapeutics’s price movement after its last earnings report?
Sigyn Therapeutics reported an EPS of -$0.668 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Sigyn Therapeutics?
Currently, no hedge funds are holding shares in SIGYD
---
Sigyn Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.90%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-3.33%
Trailing 12-Months
Company Description
Sigyn Therapeutics
Reign Sapphire Corp. is engaged in the business of processing rough sapphires and gem cutting to manufacture jewelry. It includes rings, pendants, watches, bracelets, and cuff links using a variety of metals and finishes. The company offers its products under the brands Reign Sapphire, Millennials, Coordinates Collection and Le Bloc. Reign Sapphire was founded by Joseph Segelman on December 15, 2014 and is headquartered in Beverly Hills, CA.
---
Technical Analysis
---